Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Understand the source comparison

Snap-8 for Stretch Marks: Peptide Comparison

Snap-8 (acetyl octapeptide-3) SNARE complex inhibition; reduces acetylcholine release at neuromuscular junctions Dermal-epidermal junction (neuromuscular targets) No published trials; mechanism doesn't address collagen synthesis or dermal repair Expression lin

No winner is assigned.

This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.

  • Snap-8 (acetyl octapeptide-3)
  • SNARE complex inhibition; reduces acetylcholine release at neuromuscular junctions
  • Dermal-epidermal junction (neuromuscular targets)
  • No published trials; mechanism doesn't address collagen synthesis or dermal repair
  • Expression line reduction in facial skin. Not dermal scar remodeling
  • Matrixyl (palmitoyl pentapeptide-4)
  • TGF-β upregulation; stimulates procollagen I and III synthesis in fibroblasts
  • Reticular dermis when combined with penetration enhancers
  • One pilot study showing 20% improvement in striae appearance after 12 weeks (n=23, no control group)
  • Shows mechanistic rationale for collagen stimulation; requires carrier system for dermal penetration
  • GHK-Cu (copper peptide)
  • Activates MMP-2 for remodeling; stimulates TIMP-1 to regulate collagen turnover
  • Reticular dermis via copper ion transport
  • No striae-specific trials; wound healing studies show 50–70% faster epithelialization in animal models
  • Proven collagen remodeling activity; untested specifically on striae distensae in humans
  • Palmitoyl tripeptide-1
  • Upregulates collagen I, III, and IV; reduces IL-6 inflammatory signaling
  • Papillary and reticular dermis
  • Combined with palmitoyl tetrapeptide-7 in one striae trial showing 15% texture improvement (subjective grading, n=30)
  • Anti-inflammatory and pro-collagen properties theoretically beneficial; limited standalone evidence